# Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes

> **NCT00622752** · PHASE2 · COMPLETED · sponsor: **Evotec Neurosciences GmbH** · enrollment: 90 (estimated)

## Conditions studied

- Smoking Cessation

## Interventions

- **DRUG:** EVT 302, 10 mg
- **DRUG:** placebo
- **DRUG:** Nicotine replacement therapy (NRT)
- **DEVICE:** NRT placebo

## Key facts

- **NCT ID:** NCT00622752
- **Lead sponsor:** Evotec Neurosciences GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-02
- **Primary completion:** 2008-05
- **Final completion:** 2008-05
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2008-06-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00622752

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00622752, "Effects of EVT 302 With or Without NRT on Craving and Withdrawal in Healthy Male Smokers Deprived of Cigarettes". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00622752. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*